Shionogi & Co Ltd
TSE:4507
Relative Value
The Relative Value of one Shionogi & Co Ltd stock under the Base Case scenario is 1 177 253.31 JPY. Compared to the current market price of 7 344 JPY, Shionogi & Co Ltd is Undervalued by 99%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Shionogi & Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
JP |
S
|
Shionogi & Co Ltd
TSE:4507
|
2.1T JPY | 5 | 13.7 | 10.1 | 11.4 | |
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
US |
Eli Lilly and Co
NYSE:LLY
|
737.4B USD | 21.6 | 140.7 | 63.5 | 72.9 | ||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
4T DKK | 17.3 | 48 | 34.9 | 38 | ||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | ||
JP |
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
82T JPY | 255.8 | 9 733.7 | 1 771.8 | 4 320.3 | ||
US |
Johnson & Johnson
NYSE:JNJ
|
363.9B USD | 4.4 | 9 | 12 | 15.8 | ||
US |
Merck & Co Inc
NYSE:MRK
|
326.1B USD | 5.3 | 141.4 | 33.6 | 53.3 | ||
UK |
AstraZeneca PLC
LSE:AZN
|
188.8B GBP | 5.2 | 39.6 | 140.8 | 225.8 | ||
CH |
Novartis AG
SIX:NOVN
|
181.8B CHF | 4.3 | 13.4 | 9.8 | 16.2 | ||
CH |
Roche Holding AG
SIX:ROG
|
174.4B CHF | 3 | 15.1 | 8.6 | 10.3 |